NewsCorporate ActionsShareholder Lock-In Expiry: Wakefit, ICICI Prudential AMC Among Companies with ₹21,000 Crore Worth Shares Unlocking This WeekShareholder Lock-In Expiry: Wakefit, ICICI Prudential AMC Among Companies with ₹21,000 Crore Worth Shares Unlocking This Week
Eleven companies will see shares worth ₹21,001.99 crore become eligible for trading this week as lock-in periods expire. Major unlocks include Travel Food Services (₹10,029 crore), Emcure Pharmaceuticals (₹5,862 crore), and ICICI Prudential AMC (₹1,862 crore). Other notable companies include Wakefit Innovations, Canara HSBC Life Insurance, and Canara Robeco AMC, with most stocks trading above their issue prices.
*this image is generated using AI for illustrative purposes only.
Eleven companies are set to witness shares worth ₹21,001.99 crore become eligible for trading this week as shareholder lock-in periods expire across various timeframes. The list includes several recent market listings such as Wakefit Innovations, ICICI Prudential AMC, Canara HSBC Life Insurance, Emcure Pharmaceuticals, and Canara Robeco AMC. It is important to note that the expiry of lock-in periods only makes shares eligible for trading and does not guarantee they will be sold in the open market.
Major Share Unlocks
Wakefit Innovations will see 14.90 million shares, representing 5% of its outstanding equity, become tradeable on Monday, January 12, as its one-month lock-in period ends. These shares are valued at ₹257.00 crore at current market prices. The stock closed 0.68% higher on Friday at ₹172.50, trading nearly 12% below its issue price of ₹195.00 and down 15% from its post-listing high of ₹203.50.
ICICI Prudential AMC, India's largest asset management company, will see its one-month lock-in period conclude on Friday, January 16. The unlock involves 7.00 million shares or 1% of outstanding equity worth ₹1,862.00 crore. The company manages ₹10,147.00 crore in mutual fund quarterly average assets and serves 15.50 million retail investors as of September end. The stock currently trades 23% above its issue price of ₹2,165.00.
Significant Value Unlocks
The largest unlock by value comes from Travel Food Services, where 87.20 million shares representing 66% of outstanding equity will become tradeable on Monday, January 12. These shares are worth ₹10,029.00 crore at current market prices, with the stock trading 4.50% above its issue price of ₹1,100.00.
Emcure Pharmaceuticals will see its six-month and beyond lock-in period end on Monday, January 12, unlocking 38.00 million shares or 20% of outstanding equity valued at ₹5,862.00 crore.
Additional Company Unlocks
Several other companies will experience lock-in expiries throughout the week:
| Company | Date | Shares (Million) | Equity % | Value (₹ Crore) | Price vs Issue |
|---|---|---|---|---|---|
| Canara HSBC Life Insurance | Jan 13 | 35.40 | 4% | ₹521.00 | +40% |
| Canara Robeco AMC | Jan 12 | 7.50 | 4% | ₹220.50 | +10% |
| Corona Remedies | Jan 12 | 0.90 | 2% | ₹128.69 | +35% |
| Rubicon Research | Jan 12 | 6.40 | 4% | ₹414.00 | +33% |
| Park Medi World | Jan 14 | 8.50 | 2% | ₹127.50 | -7% |
| Nephrocare Health Services | Jan 14 | 2.80 | 3% | ₹137.48 | +7% |
| Smartworks Coworking Spaces | Jan 16 | 31.20 | 27% | ₹1,441.44 | +14% |
Canara HSBC Life Insurance will conclude its three-month lock-in on Tuesday, January 13, with shares worth ₹521.00 crore becoming eligible for trading. The stock has gained nearly 40% from its issue price of ₹106.00, closing 1.16% lower on Friday at ₹147.29.
Market Performance Overview
Among the companies with expiring lock-ins, most are trading above their respective issue prices. Corona Remedies leads with a 35% gain above its issue price of ₹1,062.00, while Rubicon Research shows a 33% premium over its issue price of ₹485.00. Only Park Medi World trades below its issue price, down 7% from ₹162.00.
The collective unlock represents a significant volume of shares entering the tradeable market, though actual trading activity will depend on shareholder decisions and market conditions. These lock-in expiries are part of the standard post-IPO process where promoters and early investors gain the ability to trade their holdings after specified holding periods.
17
